Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xiangyan Zhang, Quanxin Wang, Ruiqi Zhang & Zhaolu Kong. (2023) DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation. International Journal of Radiation Biology 99:10, pages 1595-1606.
Read now
Read now
Xiangli Ma, Guangmin Mao, Rulve Chang, Fang Wang, Xiangyan Zhang & Zhaolu Kong. (2021) Down-regulation of autophagy-associated protein increased acquired radio-resistance bladder cancer cells sensitivity to taxol. International Journal of Radiation Biology 97:4, pages 507-516.
Read now
Read now
John E. Moulder. (2019) Chemical radiosensitizers: the Journal history. International Journal of Radiation Biology 95:7, pages 940-944.
Read now
Read now
Fuquan Zhang, Mingjing Shen, Li Yang, Xiaodong Yang, Ying Tsai, Peter C. Keng, Yongbing Chen, Soo Ok Lee & Yuhchyau Chen. (2017) Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer. Cancer Biology & Therapy 18:8, pages 606-615.
Read now
Read now
Rulve Chang, Hui He, Guangmin Mao & Zhaolu Kong. (2017) Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells. International Journal of Radiation Biology 93:4, pages 386-393.
Read now
Read now
Articles from other publishers (39)
Ana Blanca, Antonio Lopez-Beltran, Kevin Lopez-Porcheron, Enrique Gomez-Gomez, Alessia Cimadamore, Andreia Bilé-Silva, Rajan Gogna, Rodolfo Montironi & Liang Cheng. (2023) Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype. Cancers 15:7, pages 2149.
Crossref
Crossref
Cameron M. Callaghan, Ibrahim M. Abukhiran, Amr Masaadeh, Richard V. Van Rheeden, Amanda L. Kalen, Samuel N. RodmanIIIIII, Michael S. Petronek, Kranti A. Mapuskar, Benjamin N. George, Mitchell C. Coleman, Prabhat C. Goswami, Bryan G. Allen, Douglas R. Spitz & Joseph M. Caster. (2023) Manipulation of Redox Metabolism Using Pharmacologic Ascorbate Opens a Therapeutic Window for Radio-Sensitization by ATM Inhibitors in Colorectal Cancer. International Journal of Radiation Oncology*Biology*Physics 115:4, pages 933-944.
Crossref
Crossref
Hou-Ling Wang, Weilun Yin, Xinli Xia & Zhonghai Li. (2023) Orthologs of Human-Disease-Associated Genes in Plants Are Involved in Regulating Leaf Senescence. Life 13:2, pages 559.
Crossref
Crossref
Huan Xiao, Guan Wang, Min Zhao, Wen Shuai, Liang Ouyang & Qiu Sun. (2023) Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?. European Journal of Medicinal Chemistry 248, pages 115104.
Crossref
Crossref
Kevin J. Harrington, Charleen M. L. Chan Wah Hak, Antonio Rullan & Emmanuel Patin. 2023. Critical Issues in Head and Neck Oncology. Critical Issues in Head and Neck Oncology
23
35
.
Dana Jurkovicova, Christiana M. Neophytou, Ana Čipak Gašparović & Ana Cristina Gonçalves. (2022) DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities. International Journal of Molecular Sciences 23:23, pages 14672.
Crossref
Crossref
Yarui Zhang, Guomin Ou, Zhujing Ye, Zhou Zhou, Qianlin Cao, Mengting Li, Jingdong Wang, Jianping Cao & Hongying Yang. (2022) RPRM negatively regulates ATM levels through its nuclear translocation on irradiation mediated by CDK4/6 and IPO11. iScience 25:10, pages 105115.
Crossref
Crossref
Charleen M. L. Chan Wah Hak, Antonio Rullan, Emmanuel C. Patin, Malin Pedersen, Alan A. Melcher & Kevin J. Harrington. (2022) Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy. Frontiers in Oncology 12.
Crossref
Crossref
Pedro A. Lazo. (2022) Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?. Cancers 14:16, pages 4050.
Crossref
Crossref
Yuyan Guo, Yingtao Cui, Xing Bao, Yue Ke, Hongtao Ren, Jiyuan Pan, Liping Song & Hongbing Ma. (2022) Radiosensitization by microRNA30a-5p in a nude mouse model with subcutaneous lung-cancer xenograft*. Oncology and Translational Medicine 8:4, pages 155-164.
Crossref
Crossref
Xiaodong Dou, Xiaojiao Sun, Huixia Huang, Lan Jiang, Zefang Jin, Yameng Liu, Yang Zou, Zhongtang Li, Guiwang Zhu, Hongwei Jin, Ning Jiao, Liangren Zhang, Zhenming Liu & Lihe Zhang. (2022) Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study. European Journal of Medicinal Chemistry 233, pages 114196.
Crossref
Crossref
Xiangyan Zhang, Xiangli Ma, Quanxin Wang & Zhaolu Kong. (2022) EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cells. Translational Oncology 16, pages 101316.
Crossref
Crossref
Ilma Shakeel, Yeshfa Zaidi, Varsha Gupta, Sufian Badar, Md Khurshid Alam Khan, Bekhzod Abdullaev, Mohammad Afzal & Md. Imtaiyaz Hassan. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
179
198
.
Mathew Lozinski, Nikola A. Bowden, Moira C. Graves, Michael Fay & Paul A. Tooney. (2021) DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets. Cellular Oncology 44:5, pages 961-981.
Crossref
Crossref
Ruixue Huang & Ping-Kun Zhou. (2021) DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Jennifer R. Dungan, Xue Qin, Melissa Hurdle, Carol S. Haynes, Elizabeth R. Hauser & William E. Kraus. (2021) Genome-Wide Variants Associated With Longitudinal Survival Outcomes Among Individuals With Coronary Artery Disease. Frontiers in Genetics 12.
Crossref
Crossref
Larissa Costa de Almeida, Felipe Antunes Calil, João Agostinho Machado-Neto & Leticia Veras Costa-Lotufo. (2021) DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy. Cancer Genetics 252-253, pages 6-24.
Crossref
Crossref
Jae Ryoung Hwang, Woo Young Kim, Young-Jae Cho, Ji-Yoon Ryu, Jung-Joo Choi, Soo Young Jeong, Myeong-Sun Kim, Ji Hye Kim, E. Sun Paik, Yoo-Young Lee, Hee-Dong Han & Jeong-Won Lee. (2020) Chloroquine reverses chemoresistance via upregulation of p21WAF1/CIP1 and autophagy inhibition in ovarian cancer. Cell Death & Disease 11:12.
Crossref
Crossref
Monika Joshi, Petros Grivas, Amir Mortazavi, Paul Monk, Steven K. Clinton, Michele Sue‐Ann Woo, Sheldon L. Holder, Joseph J. Drabick & Ming Yin. (2020) Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer. Cancer Medicine 9:24, pages 9365-9372.
Crossref
Crossref
Raúl García-González, Patricia Morejón-García, Ignacio Campillo-Marcos, Marcella Salzano & Pedro A. Lazo. (2020) VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage. Cancers 12:10, pages 2986.
Crossref
Crossref
Rui-Xue Huang & Ping-Kun Zhou. (2020) DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Reem Ali, Adel Alblihy, Michael S. Toss, Mashael Algethami, Rabab Al Sunni, Andrew R. Green, Emad A. Rakha & Srinivasan Madhusudan. (2020) XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib. Therapeutic Advances in Medical Oncology 12, pages 175883592097420.
Crossref
Crossref
Casey D. Stefanski, Kaitlyn Keffler, Stephanie McClintock, Lauren Milac & Jenifer R. Prosperi. (2019) APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells. Neoplasia 21:12, pages 1143-1150.
Crossref
Crossref
Mei Hua Jin & Do-Youn Oh. (2019) ATM in DNA repair in cancer. Pharmacology & Therapeutics 203, pages 107391.
Crossref
Crossref
Tetsuya Takahashi, Tetsuro Shishido, Daisuke Kinoshita, Ken Watanabe, Taku Toshima, Takayuki Sugai, Taro Narumi, Yoichiro Otaki, Harutoshi Tamura, Satoshi Nishiyama, Takanori Arimoto, Hiroki Takahashi, Takuya Miyamoto, Tetsu Watanabe, Chang-Hoon Woo, Jun-ichi Abe, Yasuchika Takeishi, Isao Kubota & Masafumi Watanabe. (2019) Cardiac Nuclear High-Mobility Group Box 1 Ameliorates Pathological Cardiac Hypertrophy by Inhibiting DNA Damage Response. JACC: Basic to Translational Science 4:2, pages 234-247.
Crossref
Crossref
Zhenyu Ou, Yongjie Wang, Jinbo Chen, Le Tao, Li Zuo, Deepak Sahasrabudhe, Jean Joseph, Long Wang & Shuyuan Yeh. (2018) Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals. Experimental & Molecular Medicine 50:11, pages 1-11.
Crossref
Crossref
Raíssa Bernardes da Silva, Carlos Renato Machado, Aldo Rogelis Aquiles Rodrigues & André Luiz Pedrosa. (2018) Selective human inhibitors of ATR and ATM render Leishmania major promastigotes sensitive to oxidative damage. PLOS ONE 13:9, pages e0205033.
Crossref
Crossref
Jianan He, Shuai Huang, Zhenhua Lin, Jiqin Zhang, Jialin Su, Weidong Ji & Xingmo Liu. (2018) Disabled homolog 2 interactive protein functions as a tumor suppressor in osteosarcoma cells. Oncology Letters.
Crossref
Crossref
Pengbo Wen, Junfeng Xia, Xianbin Cao, Bin Chen, Yinping Tao, Lijun Wu, An Xu & Guoping Zhao. (2018) dbCRSR: a manually curated database for regulation of cancer radiosensitivity. Database 2018.
Crossref
Crossref
Laura Carrassa & Giovanna Damia. (2017) DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy. Cancer Treatment Reviews 60, pages 139-151.
Crossref
Crossref
Hui He, Rulve Chang, Tingting Zhang, Chen Yang & Zhaolu Kong. (2017) ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway. Molecular Medicine Reports 16:2, pages 1216-1222.
Crossref
Crossref
Sumit Kumar, Rajnish Kumar Singh & Ramovatar Meena. (2016) Emerging targets for radioprotection and radiosensitization in radiotherapy. Tumor Biology 37:9, pages 11589-11609.
Crossref
Crossref
CHEN YANG, HUI HE, TINGTING ZHANG, YING CHEN & ZHAOLU KONG. (2016) Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ-rays and α-particles in prostate cancer cells. Molecular Medicine Reports 14:1, pages 567-573.
Crossref
Crossref
Pounami Samadder, Rakesh Aithal, Ondrej Belan & Lumir Krejci. (2016) Cancer TARGETases: DSB repair as a pharmacological target. Pharmacology & Therapeutics 161, pages 111-131.
Crossref
Crossref
Sanhita Shrivastava, Jose Joao Mansure, Wael Almajed, Fabio Cury, Gerardo Ferbeyre, Marija Popovic, Jan Seuntjens & Wassim Kassouf. (2016) The Role of HMGB1 in Radioresistance of Bladder Cancer. Molecular Cancer Therapeutics 15:3, pages 471-479.
Crossref
Crossref
Liang Liu, Cong Xu, Jer-Tsong Hsieh, Jianping Gong & Daxing Xie. (2015) DAB2IP in cancer. Oncotarget 7:4, pages 3766-3776.
Crossref
Crossref
Patrick Maier, Linda Hartmann, Frederik Wenz & Carsten Herskind. (2016) Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. International Journal of Molecular Sciences 17:1, pages 102.
Crossref
Crossref
Corbin Jacobs, Vasu Tumati, Payal Kapur, Jingsheng Yan, Xian‐Jin Xie, Raquibul Hannan, Jer‐Tsong Hsieh, Dong Wook Nathan Kim & Debabrata Saha. (2015)
Pretreatment biopsy analysis of
DAB
2
IP
identifies subpopulation of high‐risk prostate cancer patients with worse survival following radiation therapy
. Cancer Medicine 4:12, pages 1844-1852.
Crossref
Crossref
Denis Velic, Anthony Couturier, Maria Ferreira, Amélie Rodrigue, Guy Poirier, Fabrice Fleury & Jean-Yves Masson. (2015) DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles’ Heel of Cancer. Biomolecules 5:4, pages 3204-3259.
Crossref
Crossref